Breyer Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Enable Medicine builds an integrated biological data platform that organizes and links clinical, spatial, cellular, and molecular data from patients and studies into a unified index to accelerate therapeutic discovery and diagnostics for researchers.
AI & Machine LearningBiotechData & InfrastructureMenlo Park, US
Sunil Bodapati(Executive Officer, Director)Aaron Mayer(Director)
Co-investorsAxial VCInertia Ventures
Soley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Ken V. Alwyn(Chief Financial Officer)Kurosh Ameri(Director)Yerem Yeghiazarians(Director)
Co-investorsArtisanal Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.